168 related articles for article (PubMed ID: 35456281)
21. Hope, Coping, and Quality of Life in Adults with Myasthenia Gravis.
Koopman WJ; LeBlanc N; Fowler S; Nicolle MW; Hulley D
Can J Neurosci Nurs; 2016; 38(1):56-64. PubMed ID: 27468602
[TBL] [Abstract][Full Text] [Related]
22. The Oculobulbar Facial Respiratory score is a tool to assess bulbar function in myasthenia gravis patients.
Farrugia ME; Harle HD; Carmichael C; Burns TM
Muscle Nerve; 2011 Mar; 43(3):329-34. PubMed ID: 21305562
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic and Immunoregulatory Effects of Tacrolimus in Patients with Refractory Generalized Myasthenia Gravis.
Wu H; Wang Z; Xi J; Liu J; Yan C; Song J; Wang L; Jing S; Wang Y; Zhao C
Eur Neurol; 2020; 83(5):500-507. PubMed ID: 32932253
[TBL] [Abstract][Full Text] [Related]
24. The MG-QOL15 Japanese version: validation and associations with clinical factors.
Masuda M; Utsugisawa K; Suzuki S; Nagane Y; Kabasawa C; Suzuki Y; Shimizu Y; Utsumi H; Fujihara K; Uchiyama S; Suzuki N
Muscle Nerve; 2012 Aug; 46(2):166-73. PubMed ID: 22806364
[TBL] [Abstract][Full Text] [Related]
25. Minimal Manifestation Status Indicates a Stable State in Myasthenia Gravis: A Quantitative Study.
Jiang P; Li J; Li HY; Zhang B; Yue YX; Wang SY; Zi XC; Liu SS; Li YF; Jiao LD; Li HF
Front Neurol; 2022; 13():880045. PubMed ID: 35677340
[TBL] [Abstract][Full Text] [Related]
26. Cross-sectional analysis of the Myasthenia Gravis Patient Registry: Disability and treatment.
Cutter G; Xin H; Aban I; Burns TM; Allman PH; Farzaneh-Far R; Duda PW; Kaminski HJ
Muscle Nerve; 2019 Dec; 60(6):707-715. PubMed ID: 31487038
[TBL] [Abstract][Full Text] [Related]
27. 'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab.
Vissing J; Jacob S; Fujita KP; O'Brien F; Howard JF;
J Neurol; 2020 Jul; 267(7):1991-2001. PubMed ID: 32189108
[TBL] [Abstract][Full Text] [Related]
28. Gender and quality of life in myasthenia gravis patients from the myasthenia gravis foundation of America registry.
Lee I; Kaminski HJ; Xin H; Cutter G
Muscle Nerve; 2018 Feb; ():. PubMed ID: 29466829
[TBL] [Abstract][Full Text] [Related]
29. Female sex and overweight are associated with a lower quality of life in patients with myasthenia gravis: a single center cohort study.
Wilcke H; Glaubitz S; Kück F; Anten C; Liebetanz D; Schmidt J; Zschüntzsch J
BMC Neurol; 2023 Oct; 23(1):366. PubMed ID: 37817097
[TBL] [Abstract][Full Text] [Related]
30. The MG-QOL15 for following the health-related quality of life of patients with myasthenia gravis.
Burns TM; Grouse CK; Wolfe GI; Conaway MR; Sanders DB;
Muscle Nerve; 2011 Jan; 43(1):14-8. PubMed ID: 21082698
[TBL] [Abstract][Full Text] [Related]
31. [The MG-QOL15 Japanese version: validation and associations with clinical factors].
Masuda M; Utsugisawa K; Suzuki S; Nagane Y; Ito S; Kabasawa C; Suzuki Y; Shimizu Y; Utsumi H; Fujihara K; Uchiyama S; Suzuki N
Rinsho Shinkeigaku; 2012; 52(11):1043-6. PubMed ID: 23196510
[TBL] [Abstract][Full Text] [Related]
32. Validation of the Italian version of the Myasthenia Gravis Impairment Index (MGII).
Pasqualin F; Barnett C; Guidoni SV; Albertini E; Ermani M; Bonifati DM
Neurol Sci; 2022 Mar; 43(3):2059-2064. PubMed ID: 34505205
[TBL] [Abstract][Full Text] [Related]
33. The Myasthenia Gravis-specific Activities of Daily Living scale as a useful outcome measure and in routine clinical management in Polish patients.
Rozmilowska IM; Adamczyk-Sowa MH; Czyzewski D
Neurol Neurochir Pol; 2018; 52(3):368-373. PubMed ID: 29370887
[TBL] [Abstract][Full Text] [Related]
34. Is there any relationship between quality of life and polysomnographically detected sleep parameters/disorders in stable myasthenia gravis?
Tascilar NF; Saracli O; Kurcer MA; Ankarali H; Emre U
Acta Neurol Belg; 2018 Mar; 118(1):29-37. PubMed ID: 28456888
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic effect of ofatumumab in patients with myasthenia gravis: immunoregulation of follicular T helper cells and T helper type 17 cells.
Li S; Zhang Z; Liu Z
Front Neurol; 2023; 14():1278250. PubMed ID: 38146439
[TBL] [Abstract][Full Text] [Related]
36. QMG and MG-ADL correlations: Study of eculizumab treatment of myasthenia gravis.
Howard JF; Freimer M; O'Brien F; Wang JJ; Collins SR; Kissel JT;
Muscle Nerve; 2017 Aug; 56(2):328-330. PubMed ID: 28010051
[TBL] [Abstract][Full Text] [Related]
37. Translation, cross-cultural adaptation, and validation of the french version of the 15-item Myasthenia Gravis Quality Of life scale.
Birnbaum S; Ghout I; Demeret S; Bolgert F; Eymard B; Sharshar T; Portero P; Hogrel JY
Muscle Nerve; 2017 May; 55(5):639-645. PubMed ID: 27533497
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of outcome measures for myasthenia gravis subgroups.
Luo Y; Dong X; Peng Y; Cui B; Yan C; Jin W; Li Y; Zhou R; Huang K; Yang H
J Clin Neurosci; 2021 Sep; 91():270-275. PubMed ID: 34373039
[TBL] [Abstract][Full Text] [Related]
39. The utility of a single simple question in the evaluation of patients with myasthenia gravis.
Abraham A; Breiner A; Barnett C; Katzberg HD; Bril V
Muscle Nerve; 2018 Feb; 57(2):240-244. PubMed ID: 28590545
[TBL] [Abstract][Full Text] [Related]
40. Clinical Profile and Quality of Life in Myasthenia Gravis Using MGQOL15 R(Hindi): An Indian Perspective.
Majigoudra G; Duggal AK; Chowdhury D; Koul A; Todi VK; Roshan S
Ann Indian Acad Neurol; 2023; 26(4):441-446. PubMed ID: 37970285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
